Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DR26FXQ1N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,139
Award facts
- Contract value 100% obligated
- $18,138.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $18,138.76 delivery order to AmerisourceBergen Drug Corp for Kisqali 400 mg daily dose in a quantity of 42 units. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order was placed on November 17, 2025, with an ultimate completion date of December 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 million prime vendor agreement valued through December 2026 that enables comprehensive pharmaceutical support for military healthcare programs worldwide.
Kisqali (ribociclib) is a targeted cancer therapy used primarily in the treatment of certain breast cancers. AmerisourceBergen's role as a pharmaceutical prime vendor positions the company to distribute critical specialty medications and brand-name drugs across the Defense Health Agency's medical supply chain. As a child contract under the larger SPE2DX vehicle, this delivery order reflects the company's ongoing capability to meet federal pharmaceutical procurement requirements through open competition, consistent with DLA's strategic approach of utilizing multiple contractors to support regional pharmaceutical needs across military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FXQ1N?
SPE2DR26FXQ1N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FXQ1N worth?
The government has obligated $18,139 on SPE2DR26FXQ1N.
Is contract SPE2DR26FXQ1N an order under another contract?
Yes. SPE2DR26FXQ1N is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXQ1N competed?
The extent of competition for SPE2DR26FXQ1N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award